Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

35
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
35
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

169
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
169
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

15
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
15

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Reasoning: A 72-Year-Old Man With Progressive Pan-Dysautonomia.

Neurology·2025
Same author

Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy.

Blood cancer discovery·2022
Same author

Nivolumab-associated Lambert-Eaton myasthenic syndrome and cerebellar dysfunction in a patient with a neuroendocrine tumor.

Muscle & nerve·2020
See all related articles

Related Experiment Video

Updated: Sep 5, 2025

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.4K

Autoantibody Encephalitis: Presentation, Diagnosis, and Management.

Eric Lancaster1

  • 1Department of Neurology, The University of Pennsylvania, Philadelphia, PA, USA. eric.lancaster@pennmedicine.upenn.edu.

Journal of Clinical Neurology (Seoul, Korea)
|July 7, 2022
PubMed
Summary

Autoantibody encephalitis presents with varied neurological and psychiatric symptoms. Early diagnosis via antibody testing and understanding tumor risks are crucial for effective immune therapy and patient recovery.

Keywords:
anti-NMDAR encephalitisantibodycerebellar ataxiaencephalitisparaneoplastic

More Related Videos

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

10.0K
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

18.3K

Related Experiment Videos

Last Updated: Sep 5, 2025

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

16.4K
A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
07:20

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood

Published on: January 9, 2018

10.0K
Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis
26:48

Induction and Clinical Scoring of Chronic-Relapsing Experimental Autoimmune Encephalomyelitis

Published on: July 4, 2007

18.3K

Area of Science:

  • Neurology
  • Immunology
  • Oncology

Background:

  • Autoantibody encephalitis encompasses diverse syndromes affecting mentation, movement, and cognition.
  • Diagnosis relies on detecting specific antibodies in serum or spinal fluid.
  • Associated tumor risks are critical for diagnosis and treatment strategies.

Purpose of the Study:

  • To elucidate the clinical spectrum and diagnostic approaches for autoantibody encephalitis.
  • To highlight the link between specific autoantibodies, neuronal targets, and associated paraneoplastic syndromes.
  • To discuss the principles of immune therapy in managing autoantibody encephalitis.

Main Methods:

  • Review of clinical presentations and diagnostic criteria for autoantibody encephalitis.
  • Analysis of antibody detection methods in serum and cerebrospinal fluid.
  • Correlation of specific autoantibody profiles with associated tumor types and treatment responses.

Main Results:

  • Distinct clinical syndromes characterized by neurological and psychiatric disturbances are associated with specific autoantibodies.
  • Antibody detection may require analysis of both serum and cerebrospinal fluid for optimal sensitivity.
  • Identification of associated tumors aids in diagnosis and guides therapeutic decisions.

Conclusions:

  • Autoantibody encephalitis requires comprehensive diagnostic evaluation, including antibody testing and oncological screening.
  • Understanding the pathogenic role of autoantibodies targeting neuronal receptors is key to comprehending disease mechanisms.
  • While generally responsive to immunotherapy, tailored treatment approaches are necessary for different autoantibody encephalitis subtypes.